Why is JBIO Down Today?
About Jade Biosciences, Inc. Common Stock
Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies...
Overall Confidence: 50%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.6%
Market Comparison
🔔 Get JBIO Alerts
We'll notify you when JBIO's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
JBIO has moved more than 3.0% down on 50 occasions in the past year.
Frequently Asked Questions
Why is JBIO stock down today?
JBIO is down 2.9% today on 0.6x average volume. The move appears to be driven by general market sentiment and momentum traders.
Is JBIO stock a buy or sell right now?
Based on current analysis, JBIO shows 50% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the JBIO stock price target?
JBIO is currently trading at $16.06. Based on today's momentum, the expected short-term range is $15.58 - $16.38. See long-term price prediction →
Will JBIO stock continue falling?
Our analysis shows a 45% probability that JBIO's move continues in the next 1-3 days. Key level to watch: $15.26 (support).
Is JBIO stock oversold or overbought?
JBIO's RSI (Relative Strength Index) is currently at 56.2. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for JBIO stock?
JBIO's 10-day momentum indicator is at 1.63. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is JBIO outperforming or underperforming the market?
JBIO (-2.90%) is currently significantly underperforming the market (-2.5% vs SPY). Today, the S&P 500 (SPY) is down -0.35%, and Nasdaq (QQQ) is down -0.32%.
What does MACD indicate for JBIO?
JBIO's MACD (0.16) is currently above the signal line (-0.17), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 22.0) is moderate.
Is JBIO in an uptrend or downtrend?
Based on moving average analysis, JBIO is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $14.8, 50-day SMA: $15.4.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis